Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1996-07-30
1998-01-20
Ramsuer, Robert W.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
544130, 544393, 544400, 546 20, 546118, 546191, 546194, 546199, 546208, 546210, 546224, 546225, 546234, A61K 31495, C07D29515
Patent
active
057101558
ABSTRACT:
The invention relates to new arylglycinamide derivatives of general formula I ##STR1## and the pharmaceutically acceptable salts thereof, wherein R.sup.1, R.sup.2, R.sup.3, R.sup.4, R.sup.5 and Ar have the meanings given in the specification, and the preparation and use thereof. The new compounds are valuable neurokin (tachykinin) antagonists.
REFERENCES:
patent: 3518274 (1970-06-01), Strycker
patent: 3862946 (1975-01-01), Havera
patent: 3906100 (1975-09-01), Havera
patent: 5434158 (1995-07-01), Shah
Chemical Abstracts, vol. 68, No. 3, p. No. 5717, Abstract No. 59230g (1968).
Chemical Abstracts, vol. 11, No. 13, p. No. 7, Abstract No. 54228t (1972).
K. Nagarajan et al., "A Novel Displacement Reaction on a .alpha.-Chlorodiphenylacetamides", Tetrahedron Letters, 15, pp. 1387-1390)1967.
Briem Hans
Dollinger Horst
Esser Franz
Jung Birgit
Schnorrenberg Gerd
Boehringer Ingelheim KG
Devlin Mary-Ellen
Ramsuer Robert W.
Raymond Robert P.
Stempel Alan R.
LandOfFree
Arylglycinamide derivatives, processes for the manufacture there does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Arylglycinamide derivatives, processes for the manufacture there, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Arylglycinamide derivatives, processes for the manufacture there will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-725588